• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌筛查中的过度诊断:研究设计与计算的影响。

Overdiagnosis in breast cancer screening: The impact of study design and calculations.

作者信息

Lynge Elsebeth, Beau Anna-Belle, Christiansen Peer, von Euler-Chelpin My, Kroman Niels, Njor Sisse, Vejborg Ilse

机构信息

Department of Public Health, University of Copenhagen, Øster Farimagsgade 5, DK 1014 København K, Denmark.

Department of Public Health, University of Copenhagen, Øster Farimagsgade 5, DK 1014 København K, Denmark.

出版信息

Eur J Cancer. 2017 Jul;80:26-29. doi: 10.1016/j.ejca.2017.04.018. Epub 2017 May 20.

DOI:10.1016/j.ejca.2017.04.018
PMID:28535494
Abstract

Overdiagnosis in breast cancer screening is an important issue. A recent study from Denmark concluded that one in three breast cancers diagnosed in screening areas in women aged 50-69 years were overdiagnosed. The purpose of this short communication was to disentangle the study's methodology in order to evaluate the soundness of this conclusion. We found that both the use of absolute differences as opposed to ratios; the sole focus on non-advanced tumours and the crude allocation of tumours and person-years by screening history for women aged 70-84 years, all contributed to the very high estimate of overdiagnosis. Screening affects cohorts of screened women. Danish registers allow very accurate mapping of the fate of every woman. We should be past the phase where studies of overdiagnosis are based on the fixed age groups from routine statistics.

摘要

乳腺癌筛查中的过度诊断是一个重要问题。丹麦最近的一项研究得出结论,在50 - 69岁女性的筛查区域诊断出的乳腺癌中,三分之一是过度诊断。这篇简短通讯的目的是剖析该研究的方法,以评估这一结论的可靠性。我们发现,使用绝对差异而非比率;仅关注非晚期肿瘤;以及对70 - 84岁女性按筛查史对肿瘤和人年进行粗略分配,所有这些都导致了对过度诊断的极高估计。筛查会影响接受筛查的女性队列。丹麦的登记系统能非常准确地追踪每位女性的情况。我们应该超越基于常规统计中固定年龄组进行过度诊断研究的阶段。

相似文献

1
Overdiagnosis in breast cancer screening: The impact of study design and calculations.乳腺癌筛查中的过度诊断:研究设计与计算的影响。
Eur J Cancer. 2017 Jul;80:26-29. doi: 10.1016/j.ejca.2017.04.018. Epub 2017 May 20.
2
Breast Cancer Screening in Denmark: A Cohort Study of Tumor Size and Overdiagnosis.丹麦的乳腺癌筛查:一项关于肿瘤大小和过度诊断的队列研究。
Ann Intern Med. 2017 Mar 7;166(5):313-323. doi: 10.7326/M16-0270. Epub 2017 Jan 10.
3
[Discrepancies and overdiagnosis in breast cancer organized screening. A "methodology" systematic review].[乳腺癌组织筛查中的差异与过度诊断。一项“方法学”系统评价]
Rev Epidemiol Sante Publique. 2018 Nov;66(6):395-403. doi: 10.1016/j.respe.2018.08.007. Epub 2018 Oct 11.
4
Breast cancer incidence trends in Norway and estimates of overdiagnosis.挪威乳腺癌发病率趋势及过度诊断估计
J Med Screen. 2017 Jun;24(2):83-91. doi: 10.1177/0969141316668379. Epub 2016 Oct 17.
5
As you like it: How the same data can support manifold views of overdiagnosis in breast cancer screening.随你喜欢:同一数据如何能支持乳腺癌筛查中多种过度诊断的观点。
Int J Cancer. 2018 Sep 15;143(6):1287-1294. doi: 10.1002/ijc.31420. Epub 2018 Apr 25.
6
Extrapolation of pre-screening trends: Impact of assumptions on overdiagnosis estimates by mammographic screening.预筛选趋势推断:假设对乳腺 X 线筛查过度诊断估计的影响。
Cancer Epidemiol. 2016 Jun;42:147-53. doi: 10.1016/j.canep.2016.04.015. Epub 2016 May 3.
7
What is overdiagnosis and why should we take it seriously in cancer screening?什么是过度诊断,以及为什么我们应该在癌症筛查中认真对待它?
Public Health Res Pract. 2017 Jul 26;27(3):2731722. doi: 10.17061/phrp2731722.
8
Overdiagnosis in the population-based organized breast cancer screening program estimated by a non-homogeneous multi-state model: a cohort study using individual data with long-term follow-up.基于人群的乳腺癌筛查计划中过度诊断的估计:使用具有长期随访的个体数据的非同质多状态模型的队列研究。
Breast Cancer Res. 2018 Dec 17;20(1):153. doi: 10.1186/s13058-018-1082-z.
9
Benefit-to-harm ratio of the Danish breast cancer screening programme.丹麦乳腺癌筛查项目的利弊比。
Int J Cancer. 2017 Aug 1;141(3):512-518. doi: 10.1002/ijc.30758. Epub 2017 May 10.
10
Estimating the magnitude of cancer overdiagnosis in Australia.估算澳大利亚癌症过度诊断的程度。
Med J Aust. 2020 Mar;212(4):163-168. doi: 10.5694/mja2.50455. Epub 2019 Dec 19.

引用本文的文献

1
Personalized screening based on risk and density: prevalence data from the RIBBS study.基于风险和密度的个性化筛查:RIBBS研究的患病率数据。
Radiol Med. 2025 Mar 21. doi: 10.1007/s11547-025-01981-5.
2
Breast cancer detection accuracy of AI in an entire screening population: a retrospective, multicentre study.人工智能在整个人群筛查中检测乳腺癌的准确性:一项回顾性、多中心研究。
Cancer Imaging. 2023 Dec 20;23(1):127. doi: 10.1186/s40644-023-00643-x.
3
Costs and Effects of Implementing Digital Tomosynthesis in a Population-Based Breast Cancer Screening Program: Predictions Using Results from the To-Be Trial in Norway.
在基于人群的乳腺癌筛查项目中实施数字断层合成技术的成本与效果:基于挪威即将开展的试验结果进行的预测
Pharmacoecon Open. 2022 Jul;6(4):495-507. doi: 10.1007/s41669-022-00343-5. Epub 2022 Jul 7.
4
Quality of Informed Consent in Mammography Screening-The Polish Experience.乳腺 X 光筛查中的知情同意质量-波兰经验。
Int J Environ Res Public Health. 2022 May 31;19(11):6735. doi: 10.3390/ijerph19116735.
5
Breast cancer mortality and overdiagnosis after implementation of population-based screening in Denmark.丹麦实施基于人群的筛查后乳腺癌死亡率及过度诊断情况
Breast Cancer Res Treat. 2020 Dec;184(3):891-899. doi: 10.1007/s10549-020-05896-9. Epub 2020 Aug 30.
6
Outcome of breast cancer screening in Denmark.丹麦的乳腺癌筛查结果。
BMC Cancer. 2017 Dec 28;17(1):897. doi: 10.1186/s12885-017-3929-6.